Lifestyle Modification and Prevention of Type 2 Diabetes in Overweight Japanese With Impaired Fasting Glucose Levels A Randomized Controlled Trial

被引:215
|
作者
Saito, Toshikazu [1 ]
Watanabe, Makoto [6 ]
Nishida, Junko
Izumi, Tomono
Omura, Masao
Takagi, Toshikazu [3 ]
Fukunaga, Ryuzo [7 ]
Bandai, Yasutsugu [2 ]
Tajima, Naoko [4 ]
Nakamura, Yosikazu [8 ]
Ito, Masaharu [5 ]
机构
[1] Social Insurance Chuo Gen Hosp, Dept Internal Med, Shinjyuku Ku, Tokyo 1690073, Japan
[2] Social Insurance Chuo Gen Hosp, Dept Surg, Tokyo 1690073, Japan
[3] Ikebukuro Hosp, Dept Internal Med, Tokyo, Japan
[4] Jikei Univ, Sch Med, Dept Internal Med, Tokyo, Japan
[5] All Japan Federat Social Insurance Assoc, Tokyo, Japan
[6] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Osaka, Japan
[7] Hoshigaoka Employees Pens Welf Hosp, Dept Strokol, Osaka, Japan
[8] Jichi Med Univ, Dept Publ Hlth, Shimotsuke, Tochigi, Japan
关键词
PREVALENCE; INTERVENTION; TOLERANCE; IGT;
D O I
10.1001/archinternmed.2011.275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous studies demonstrated that intensive lifestyle modification can prevent type 2 diabetes mellitus among those with impaired glucose tolerance, but similar beneficial results have not been proved among those with impaired fasting glucose levels. We investigated the efficacy of lifestyle modification on type 2 diabetes incidence among those with impaired fasting glucose levels. Methods: The present study was an unmasked, multicenter, randomized, controlled trial. A total of 641 overweight Japanese (aged 30-60 years) with impaired fasting glucose levels were recruited nationwide in Japan and randomly assigned to a frequent intervention group (n=311) or a control group (n=330). For 36 months after randomization, the frequent intervention group received individual instructions and follow-up support for lifestyle modification from the medical staff 9 times. The control group received similar individual instructions 4 times at 12-month intervals during the same period. The primary outcome was type 2 diabetes incidence in annual 75-g oral glucose tolerance tests, diagnosed according to World Health Organization criteria. Results: There were no significant differences between the allocation groups in baseline characteristics and dropout rates. Estimated cumulative incidences of type 2 diabetes were 12.2% in the frequent intervention group and 16.6% in the control group. Overall, the adjusted hazard ratio in the frequent intervention group was 0.56 (95% confidence interval, 0.36-0.87). In the post hoc subgroup analyses, the hazard ratio reduced to 0.41 (95% confidence interval, 0.24-0.69) among participants with impaired glucose tolerance at baseline, and to 0.24 (0.12-0.48) among those with baseline hemoglobin A(1c) levels of 5.6% or more (the Japan Diabetes Society method). Such risk reduction was not observed among those with isolated impaired fasting glucose findings or baseline hemoglobin A(1c) levels of less than 5.6%. Conclusions: Lifestyle modifications can prevent type 2 diabetes among overweight Japanese with impaired fasting glucose levels. In addition, identifying individuals with more deteriorated glycemic status by using 75-g oral glucose tolerance test findings or, especially, measurement of hemoglobin A(1c) levels, could enhance the efficacy of lifestyle modifications.
引用
收藏
页码:1352 / 1360
页数:9
相关论文
共 50 条
  • [41] Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup
    Yamada, Tamaki
    Fukatsu, Mitsuru
    Suzuki, Sadao
    Wada, Tsuneya
    Yoshida, Takashi
    Joh, Takashi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (02) : 352 - 356
  • [42] Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes
    Pixner, Thomas
    Chaikouskaya, Tatsiana
    Lauth, Wanda
    Zimmermann, Georg
    Moerwald, Katharina
    Lischka, Julia
    Furthner, Dieter
    Awender, Elisabeth
    Geiersberger, Sabine
    Maruszczak, Katharina
    Forslund, Anders
    Anderwald, Christian-Heinz
    Cadamuro, Janne
    Weghuber, Daniel
    Bergsten, Peter
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [43] Serum γ-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men
    Nakanishi, N
    Nishina, K
    Li, W
    Sato, M
    Suzuki, K
    Tatara, K
    [J]. JOURNAL OF INTERNAL MEDICINE, 2003, 254 (03) : 287 - 295
  • [44] Prevalence of type 2 diabetes mellitus and impaired fasting glucose, and their associated lifestyle factors among teachers in the CLUSTer cohort
    Ng, Yit Han
    Moy, Foong Ming
    Hairi, Noran Naqiah
    Bulgiba, Awang
    [J]. PEERJ, 2024, 12
  • [45] Results of a 2-year lifestyle intervention for type 2 diabetes: the Reach Ahead for Lifestyle and Health -Diabetes randomized controlled trial
    Wexler, Deborah J.
    Chang, Yuchiao
    Levy, Douglas E.
    Porneala, Bianca
    McCarthy, Jeanna
    Romero, Anthony Rodriguez
    Goldman, Valerie
    Copeland, Paul M.
    Steppel-Reznik, Jeanne
    Delahanty, Linda M.
    [J]. OBESITY, 2022, 30 (10) : 1938 - 1950
  • [46] Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial
    Inoue, Megumi
    Shiramoto, Masanari
    Oura, Tomonori
    Nasu, Risa
    Nakano, Masako
    Takeuchi, Masakazu
    [J]. DIABETES THERAPY, 2019, 10 (03) : 1019 - 1027
  • [47] Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial
    Megumi Inoue
    Masanari Shiramoto
    Tomonori Oura
    Risa Nasu
    Masako Nakano
    Masakazu Takeuchi
    [J]. Diabetes Therapy, 2019, 10 : 1019 - 1027
  • [48] Postprandial glucose-lowering effects of fermented red ginseng in subjects with impaired fasting glucose or type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
    Oh, Mi-Ra
    Park, Soo-Hyun
    Kim, Sun-Young
    Back, Hyang-Im
    Kim, Min-Gul
    Jeon, Ji-Young
    Ha, Ki-Chan
    Na, Won-Taek
    Cha, Youn-Soo
    Park, Byung-Hyun
    Park, Tae-sun
    Chae, Soo-Wan
    [J]. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 14
  • [49] Postprandial glucose-lowering effects of fermented red ginseng in subjects with impaired fasting glucose or type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
    Mi-Ra Oh
    Soo-Hyun Park
    Sun-Young Kim
    Hyang-Im Back
    Min-Gul Kim
    Ji-Young Jeon
    Ki-Chan Ha
    Won-Taek Na
    Youn-Soo Cha
    Byung-Hyun Park
    Tae-sun Park
    Soo-Wan Chae
    [J]. BMC Complementary and Alternative Medicine, 14
  • [50] The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance
    Herman, WH
    Hoerger, TJ
    Brandle, M
    Hicks, K
    Sorensen, S
    Zhang, P
    Hamman, RF
    Ackermann, RT
    Engelgau, MM
    Ratner, RE
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) : 323 - 332